The Flu Shot Paradox: Why Swiss Patients and Doctors Are Losing Faith in the Annual Ritual

As autumn arrives in Switzerland, so does the predictable public relations machinery of the Federal Office of Public Health. Every year, the health authorities roll out their ritualistic warnings, urging vulnerable groups—from pregnant women to everyone over 65—to roll up their sleeves for the seasonal flu shot. Yet, despite state encouragement, the Swiss population remains unimpressed. Only 37 percent of citizens over the age of 65 opted for the jab last winter, a figure that reveals a distinct lack of enthusiasm for bureaucratic health advice.

This reluctance is not merely a symptom of public apathy. Medical professionals themselves are quietly acknowledging what health officials prefer to downplay: the current flu vaccines are simply not very good. Philip Tarr, head of infectious diseases at the Kantonsspital Baselland, points out that many physicians view the effort as disproportionate to the actual outcome. For decades, the dogma of high vaccine efficacy was treated as an unassailable truth, stifling incentives to invest in genuinely superior alternatives. When market innovation is replaced by institutional complacency, better medical solutions fail to materialize.

Unsurprisingly, the authorities in Bern reject such skepticism. In an official stance, the Federal Office of Public Health stated that numerous large studies demonstrate that the flu vaccination significantly reduces the risk of severe disease courses. According to their figures, the shot lowers flu-related hospitalizations among older adults by around 40 percent and cuts flu-related deaths by roughly 35 to 50 percent. From the perspective of the state apparatus, the broad statistics are sufficient to justify sweeping annual directives.

Yet medicine operates on individual risk profiles rather than state-administered averages. Christoph Fux, chief physician for infectious diseases at the Kantonsspital Aarau, notes that the vaccine primarily serves those at extreme risk, such as recent heart attack or stroke patients, where vaccinating just thirty people can prevent a major medical event. For the majority of healthy senior citizens, however, the individual benefit remains marginal, serving mostly to reduce the general background circulation of the virus.

What the official public health apparatus often glosses over is that health protection relies as much on individual responsibility as on state directives. Simple, targeted measures like standard handwashing and wearing a mask when experiencing a runny nose effectively curb viral transmission without requiring heavy-handed institutional persuasion. Perhaps the persistent low vaccination rates among the Swiss are less a sign of irrational skepticism and more a sound reaction to an imperfect product.

Written by Thomas Nussbaumer thomas.nussbaumer@alpineweekly.com